Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 40 thumbs up ...

Okay.

Okay, we know that.

And how has that action enhanced shareholder value (the second part of my question). Ah yes, .146689737. Obviously the arrangement, the delegation, has failed to do much enhancing.

It does appear that we own a portfolio that is a "patent litigators dream". It is too bad the custodians of the asset were unable to monetize the portfolio into a patent 'owners' dream.

Share
New Message
Please login to post a reply